Clinical Trial Update: Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934 [Phase 2]

View source ↗

Summary

Phase 2 trial comparing maintenance treatment of anemia in pre-dialysis chronic kidney disease patients on darbepoetin versus BAY85-3934 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• BAY85-3934
• Darbepoetin (darbepoetin alfa)

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED